What question did this study set out to answer?

The aim is to develop new Fe(III)-based contrast agents using pyridophane macrocyclic ligands for MRI applications.

February 27, 2026Open Access

NODESINNDIANAD3. 2Patent on Fe (III) -based MRI contrast agents

The aim is to develop new Fe(III)-based contrast agents using pyridophane macrocyclic ligands for MRI applications.
Synthesis of pyridophane macrocyclic ligands
Formation of Fe(III) complexes
Characterization for MRI suitability
Novel contrast agents show promising properties for MRI
Enhanced imaging quality compared to existing agents

Pyridophane macrocyclic ligands and Fe(III) complexes thereof, for MRI applications

Building similarity graph...

Analyzing shared references across papers

Mauro Gastón Nacimento Botta (Wed,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Mauro Gastón Nacimento Botta

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”

Building similarity graph...

Analyzing shared references across papers